RESUMEN
BACKGROUND: Currently, there are no effective medications to reverse periodontal disease (PD)-induced bone loss. The objective of this study was to test a new anabolic compound, LLP2A-Ale, or with the combination treatment of mesenchymal stromal cell (MSC), in the treatment of bone loss secondary to PD. METHODS: PD was induced in mice by placing a ligature around the second right molar. At one week after disease induction, the mice were treated with placebo, LLP2A-Ale, MSCs, or combination of LLP2A-Ale + MSCs, and euthanized at week 4. RESULTS: We found that PD induced alveolar bone loss that was associated with reduced bone formation. LLP2A-Ale alone or in combination with MSCs sustained alveolar bone formation and reversed alveolar bone loss. Additionally, PD alone caused systemic inflammation and increased the circulating levels of G-CSF, IP-10, MIP-1a, and MIP2, which were suppressed by LLP2A-Ale +/- MSCs. LLP2A-Ale +/- MSCs increased bone formation at the peripheral skeletal site (distal femur), which was otherwise suppressed by PD. CONCLUSION: Our findings indicated that LLP2A-Ale treatment rescued alveolar bone loss caused by PD, primarily by increasing bone formation. LLP2A-Ale also attenuated the circulating levels of a series of inflammatory cytokines and reversed the PD-induced suppression of systemic bone formation.
Asunto(s)
Pérdida de Hueso Alveolar/tratamiento farmacológico , Dipéptidos/uso terapéutico , Modelos Animales de Enfermedad , Enfermedades Maxilares/tratamiento farmacológico , Osteogénesis/efectos de los fármacos , Periodontitis/tratamiento farmacológico , Compuestos de Fenilurea/uso terapéutico , Pérdida de Hueso Alveolar/diagnóstico por imagen , Animales , Dipéptidos/farmacología , Masculino , Enfermedades Maxilares/diagnóstico por imagen , Ratones , Ratones Endogámicos BALB C , Osteogénesis/fisiología , Periodontitis/diagnóstico por imagen , Compuestos de Fenilurea/farmacologíaRESUMEN
Central giant cell granuloma (CGCG) is a benign intraosseous lesion of the head and neck with potential for aggressive and locally destructive behaviour. Lesions of the maxilla tend to expand more than those of the mandible due to the thinner cortices and spongy tissue of this location. Surgical removal is the most common treatment; however, it may be disfiguring in aggressive cases, especially for lesions located in the maxilla. Alternative treatments, such as intralesional corticosteroid injections, have been performed with satisfactory results. We report a case of a 12-year-old female patient with a CGCG of the left maxilla that was treated with 40 doses of intralesional triamcinolone acetonide infiltrations combined with alendronate sodium and calcium carbonate. Clinical and imaging follow-up over 12 years demonstrates improvement in the patient's condition.
Asunto(s)
Corticoesteroides/administración & dosificación , Difosfonatos/administración & dosificación , Granuloma de Células Gigantes/tratamiento farmacológico , Granuloma de Células Gigantes/patología , Enfermedades Maxilares/tratamiento farmacológico , Enfermedades Maxilares/patología , Alendronato/administración & dosificación , Antiinflamatorios/administración & dosificación , Conservadores de la Densidad Ósea/administración & dosificación , Carbonato de Calcio/administración & dosificación , Niño , Femenino , Estudios de Seguimiento , Humanos , Inyecciones Intralesiones , Tiempo , Triamcinolona Acetonida/administración & dosificaciónRESUMEN
OBJETIVO: La osteonecrosis de maxilares (ONM) es una enfermedad recientemente descrita cuya etiopatogenia es desconocida, aunque se ha atribuido, entre otras causas, al tratamiento prolongado con bifosfonatos. Sin embargo, mientras que la ONM es una patología localizada, la acción de los bifosfonatos es generalizada, es decir, afecta a todos los huesos. No hay estudios que muestren el estado óseo general de los pacientes con ONM. Con este trabajo hemos querido estudiar en pacientes afectos de ONM dicho estado general mediante medidas cuantitativas y estimaciones cualitativas del hueso por medio de la densidad mineral ósea (DMO) y el trabecular bone score (TBS) y los parámetros ultrasonográficos en el calcáneo (QUS), además de la presencia de otras enfermedades y la toma de fármacos (especialmente los bifosfonatos) en los pacientes con ONM que pudieran participar en su etiopatogenia. MATERIAL Y MÉTODO: Estudio observacional y transversal de casos y controles, realizado en 304 pacientes de ambos sexos, en los que el grupo de casos (grupo I) estaba formado por 24 pacientes que habían sufrido una ONM, mientras que el grupo control (grupo II) estaba formado por 280 pacientes que no presentaban ONM y que recibían bifosfonatos desde un mínimo de 5 años por causas diversas. A todos ellos se les realizó una densitometría ósea (DXA, Hologic 4500 Discovery®) en la columna lumbar y en la extremidad proximal del fémur. Además, se les realizó mediciones del TBS en la columna lumbar, así como de los parámetros ultrasonográficos en el calcáneo (Hologic, Sahara®) en el pie dominante (QUS). RESULTADOS: Los pacientes afectos de ONM tenían una mayor comorbilidad que los controles, con una mayor prevalencia de las siguientes enfermedades: diabetes mellitus, cáncer, artritis reumatoide, hipertiroidismo, cardiopatía, arritmias, insuficiencia cardíaca e hipercolesterolemia. Por ello, el consumo de corticoides, (orales e inhalados), anticoagulantes, hipnóticos, bifosfonatos i.v. (zoledronato), y quimioterapia antineoplásica fue también mayor entre los pacientes afectos de ONM que los pacientes controles. Sin embargo, entre los pacientes con ONM el porcentaje que tomaba bifosfonatos orales fue menor. Los valores densitométricos (DMO medida en la columna lumbar L2-L4, cuello femoral y total de cadera) fueron más elevados en los pacientes con ONM en comparación con los de los controles. El TBS no mostró diferencias estadísticamente significativas entre ambos grupos, y los ultrasonidos presentaron valores más elevados de QUI y SOS en los pacientes con ONM que en los controles. La prevalencia de fracturas por fragilidad fue similar en ambos grupos. CONCLUSIONES: Nuestros pacientes afectos de ONM mostraron una mayor comorbilidad y un mayor consumo de fármacos que los pacientes del grupo control, a excepción de bifosfonatos orales. Por otro lado, tanto la DMO como los parámetros ultrasonográficos mostraron valores más elevados en los pacientes con ONM que los controles. Si consideramos la DXA como una técnica medidora de la cantidad de masa ósea, y el TBS y la ultrasonografía de calcáneo técnicas estimadoras de aspectos cualitativos del hueso, podemos suponer que ni la cantidad ni la calidad óseas en general parecen estar afectadas en la ONM, siendo probablemente otro su mecanismo etiopatogénico. Los bifosfonatos orales no parecen estar entre los fármacos que participen en la etiología de la ONM, aunque sí los bifosfonatos más potentes que se administran por vía intravenosa, si bien no pueden considerarse independientemente de la patología subyacente para la cual se administran
OBJECTIVE: Osteonecrosis of the jaw (ONJ) is a recently reported disease whose origin and development are unknown, although prolonged bisphosphonate treatment has been attributed, among other causes. While ONJ is a localized condition, the action of bisphosphonates is widespread and affects all bones. No studies show the general bone status of patients with ONJ. Our study examines the general condition in patients with ONJ using quantitative measurements and qualitative estimates of bone by means of bone mineral density (BMD) and trabecular bone score (TBS) and ultrasound parameters in the calcaneus (QUS), along with other diseases and the taking of drugs (especially bisphosphonates) in patients with ONJ who may be involved in the pathogenesis. MATERIAL AND METHOD: Observational and cross-sectional study of cases and controls, conducted in 304 patients of both sexes, in which the case group (group I) was formed by 24 patients who had suffered ONJ. The control group (group II) contained 280 patients who did not present ONJ and who received bisphosphonates over at least 5 years for various reasons. All of them underwent bone densitometry (DXA, Hologic 4500 Discovery®) in the lumbar spine and proximal femur. In addition, TBS measurements were made in the lumbar spine, as well as ultrasound parameters in the calcaneus (Hologic, Sahara®) in the dominant foot (QUS). RESULTS: Patients suffering ONJ presented greater comorbidity than controls, with a higher prevalence of diabetes mellitus, cancer, rheumatoid arthritis, hyperthyroidism, heart disease, arrhythmias, heart failure and hypercholesterolemia. Therefore, the consumption of corticosteroids, (oral and inhaled), anticoagulants, hypnotics, bisphosphonates i.v. (zoledronate), and antineoplastic chemotherapy was also higher among patients with ONJ than control patients. However, among the patients with ONJ the percentage taking oral bisphosphonates was lower. Densitometric values (BMD measured in lumbar spine L2-L4, femoral neck and total hip) were higher in patients with ONJ compared to those in controls. The TBS showed no statistically significant differences between the two groups, and the ultrasound showed higher values of QUI and SOS in patients with ONJ than in controls. The prevalence of fragility fractures was similar in both groups. CONCLUSIONS: Patients with ONJ in our study presented greater comorbidity and a higher consumption of drugs than the patients in the control group, except for oral bisphosphonates. On the other hand, both BMD and ultrasound showed higher values in patients with ONJ than in controls. If we consider DXA as a technique for measuring the amount of bone mass, and TBS and calcaneal ultrasound estimating qualitative aspects of bone, we could assume that neither bone quantity nor quality in general seems to be affected in ONJ, and that its etiopathogenic mechanism is probably another. Oral bisphosphonates do not appear to be among the drugs involved in ONJ's origin and development, but the most potent and intravenously administered bisphosphonates are, although they cannot be considered independently of the underlying disease for which they are administered
Asunto(s)
Humanos , Masculino , Femenino , Persona de Mediana Edad , Anciano , Anciano de 80 o más Años , Osteonecrosis/tratamiento farmacológico , Enfermedades Maxilares/tratamiento farmacológico , Difosfonatos/uso terapéutico , Estudios de Casos y Controles , Osteonecrosis/diagnóstico por imagen , Enfermedades Maxilares/diagnóstico por imagen , Estudios Transversales , Densitometría , Absorciometría de FotónRESUMEN
OBJECTIVE: Tuberculosis is a chronic granulomatous lesion, which primarily has an affinity for the lungs. It can involve other sites like lymph nodes, kidney, oral cavity. Infection of the oral cavity by M. tuberculosis can be as a Primary infection or as a Secondary infection. Primary presentation of oral tuberculosis is in the form of the chronic non healing ulcer. A Primary infection or an Asymptomatic Secondary infection can impose a great diagnostic dilemma, as it may mimic neoplasia. Here we present a case of a 32-year-old asymptomatic female with secondary infection.
Asunto(s)
Granuloma/diagnóstico , Enfermedades Maxilares/diagnóstico , Neoplasias de la Boca/diagnóstico , Úlceras Bucales/diagnóstico , Tuberculosis Bucal/diagnóstico , Adulto , Antituberculosos/uso terapéutico , Técnicas Bacteriológicas , Biopsia , Diagnóstico Diferencial , Femenino , Granuloma/tratamiento farmacológico , Granuloma/microbiología , Humanos , Enfermedades Maxilares/tratamiento farmacológico , Enfermedades Maxilares/microbiología , Úlceras Bucales/tratamiento farmacológico , Úlceras Bucales/microbiología , Valor Predictivo de las Pruebas , Radiografía Panorámica , Tuberculosis Bucal/tratamiento farmacológico , Tuberculosis Bucal/microbiologíaRESUMEN
RESUMEN: Las infecciones en el territorio maxilofacial, son cuadros frecuentes, de origen polimicrobiano, con manifestaciones clínicas muy variables y que están asociadas a múltiples vías de ingreso de los microorganismos al territorio. Un gran porcentaje de estas infecciones se origina en la cavidad oral, principalmente en lesiones bacterianas que sufren los dientes. La compleja anatomía de la cabeza y el cuello, permiten que muchas de estas infecciones se diseminen por espacios profundos, llegando a comprometer órganos o regiones anatómicas adyacentes, que pueden llevar a cuadros clínicos de alto riesgo vital. Los casos clínicos presentados en este artículo corresponden a pacientes tratados en el hospital San Juan de Dios a causa de procesos infecciosos del territorio maxilofacial, por equipos multidisciplinarios.
ABSTRACT: Infections in the maxillofacial territory are frequent cases of polymicrobial origin, with very variable clinical manifestations and are associated with multiple entering pathways of microorganisms in the territory. A large percentage of these infections originate in the oral cavity, mainly in bacterial lesions that undergo experienced by the teeth. The complex anatomy of the head and neck allows many of these infections to spread through deep spaces, leading to compromising adjacent organs or anatomical regions, which can lead to high-risk clinical conditions. The clinical cases presented in this article correspond to patients treated at the San Juan de Dios hospital because of infectious processes of the maxillofacial territory, by multidisciplinary teams.
Asunto(s)
Humanos , Masculino , Adulto , Anciano , Enfermedades Maxilares/cirugía , Enfermedades Maxilares/microbiología , Enfermedades Maxilares/tratamiento farmacológico , Cara/microbiología , Drenaje , Fascitis Necrotizante/complicaciones , Tumor Hinchado de Pott/complicaciones , Infecciones/cirugía , Infecciones/tratamiento farmacológico , Antibacterianos/uso terapéuticoRESUMEN
An 18-month-old neutered male labradoodle was treated with surgical debridement for maxillary osteomyelitis and sequestrum formation. Histopathologic findings of the necrotic bone were consistent with Cryptococcus subspecies, confirmed with latex agglutination serum titer testing. The patient responded to a combination of fluconazole and surgical debridement and was titer negative after 8 months of medical therapy. The patient never exhibited signs of systemic illness which is commonly reported with cryptococcosis. Cryptococcus subspecies infection in dogs in the Pacific Northwest is part of an ongoing outbreak in the region, first reported in 2001, and is associated with specific risk factors. This is the first published case of oral cryptococcosis from primary inoculation.
Asunto(s)
Criptococosis/veterinaria , Enfermedades de los Perros/diagnóstico , Enfermedades Maxilares/veterinaria , Osteomielitis/veterinaria , Osteonecrosis/veterinaria , Animales , Antifúngicos/administración & dosificación , Criptococosis/diagnóstico , Criptococosis/tratamiento farmacológico , Criptococosis/cirugía , Cryptococcus/fisiología , Desbridamiento/veterinaria , Enfermedades de los Perros/tratamiento farmacológico , Enfermedades de los Perros/cirugía , Perros , Fluconazol/administración & dosificación , Masculino , Enfermedades Maxilares/diagnóstico , Enfermedades Maxilares/tratamiento farmacológico , Enfermedades Maxilares/cirugía , Osteomielitis/diagnóstico , Osteomielitis/tratamiento farmacológico , Osteomielitis/cirugía , Osteonecrosis/diagnóstico , Osteonecrosis/tratamiento farmacológico , Osteonecrosis/cirugíaRESUMEN
BACKGROUND: This case illustrates the importance of prompt assessment and treatment of orbital cellulitis. In fact the ocular signs and symptoms may be associated with systemic complications which should be investigated and identified as soon as possible to avoid a poor prognosis. CASE PRESENTATION: A 46-year-old white woman presented to our emergency room with proptosis, ophthalmoplegia, and conjunctival chemosis of her left eye. An ophthalmologist, having diagnosed orbital cellulitis in her left eye, suspected a cavernous sinus thrombosis. Hematochemical and radiological examinations confirmed the cavernous sinus thrombosis and also showed septic pulmonary embolism. A blood culture indicated Streptococcus constellatus, which is a member of the Peptostreptococcus family, a saprophyte of the oral mucosa that can be pathogenic in immunocompromised persons. The odontogenic origin was then confirmed by dental radiography which showed a maxillary abscess. Her eye signs regressed after antibiotic and anticoagulant therapy. CONCLUSIONS: This complex case shows the importance of a multidisciplinary approach for the management of orbital cellulitis, for the prompt diagnosis and treatment of eye injuries and possible complications, so as to avoid serious and permanent sequelae.
Asunto(s)
Absceso/microbiología , Trombosis del Seno Cavernoso/diagnóstico , Exoftalmia/microbiología , Enfermedades Maxilares/microbiología , Oftalmoplejía/microbiología , Celulitis Orbitaria/diagnóstico , Embolia Pulmonar/diagnóstico , Absceso/diagnóstico por imagen , Absceso/tratamiento farmacológico , Antibacterianos/uso terapéutico , Anticoagulantes/uso terapéutico , Trombosis del Seno Cavernoso/tratamiento farmacológico , Trombosis del Seno Cavernoso/fisiopatología , Exoftalmia/etiología , Femenino , Humanos , Enfermedades Maxilares/diagnóstico por imagen , Enfermedades Maxilares/tratamiento farmacológico , Persona de Mediana Edad , Oftalmoplejía/etiología , Celulitis Orbitaria/tratamiento farmacológico , Celulitis Orbitaria/fisiopatología , Embolia Pulmonar/tratamiento farmacológico , Embolia Pulmonar/fisiopatología , Radiografía Dental , Infecciones Estreptocócicas/complicaciones , Streptococcus constellatus/aislamiento & purificación , Tomografía Computarizada por Rayos X , Resultado del TratamientoRESUMEN
BACKGROUND: Disseminated Histoplasmosis (DH) is a rare manifestation of Acquired Immune Deficiency Syndrome (AIDS) in European countries. Naso-maxillar osteolysis due to Histoplasma capsulatum var. capsulatum (Hcc) is unusual in endemic countries and has never been reported in European countries. Differential diagnoses such as malignant tumors, cocaine use, granulomatosis, vasculitis and infections are more frequently observed and could delay and/or bias the final diagnosis. CASE PRESENTATION: We report the case of an immunocompromised patient infected by Human Immunodeficiency Virus (HIV) with naso-maxillar histoplasmosis in a non-endemic country. Our aim is to describe the clinical presentation, the diagnostic and therapeutic issues. A 53-year-old woman, originated from Haiti, was admitted in 2016 for nasal deformation with alteration of general condition evolving for at least 6 months. HIV infection was diagnosed in 2006 and classified at AIDS stage in 2008 due to cytomegalovirus infection associated with pulmonary histoplasmosis. At admission, CD4 cell count was 9/mm3. Surgical biopsies were performed and ruled out differential or associated diagnoses. Mycological cultures identified Hcc and Blood Polymerase Chain Reaction (PCR) for Hcc was positive. The patient was given daily Amphothericin B liposomal infusion during 1 month. Hcc PCR became negative in the blood under treatment, and then oral switch by itraconazole was introduced. Antiretroviral treatment was reintroduced after a 3-week histoplasmosis treatment. Normalization of naso-maxillar mucosa enabled a palatal prosthesis. CONCLUSION: Naso-maxillar histoplasmosis is extremely rare; this is the first case ever reported in a non-endemic country. Differential diagnoses must be ruled out by conducting microbiologic tools and histological examinations on surgical biopsies. Early antifungal treatment should be initiated in order to prevent DH severe outcomes.
Asunto(s)
Infecciones Oportunistas Relacionadas con el SIDA/etiología , Histoplasmosis/tratamiento farmacológico , Histoplasmosis/etiología , Osteólisis/etiología , Infecciones Oportunistas Relacionadas con el SIDA/tratamiento farmacológico , Infecciones Oportunistas Relacionadas con el SIDA/microbiología , Síndrome de Inmunodeficiencia Adquirida/tratamiento farmacológico , Fármacos Anti-VIH/uso terapéutico , Antifúngicos/uso terapéutico , Recuento de Linfocito CD4 , Infecciones por Citomegalovirus/diagnóstico , Infecciones por Citomegalovirus/etiología , Diagnóstico Diferencial , Femenino , Infecciones por VIH/complicaciones , Infecciones por VIH/tratamiento farmacológico , Haití , Histoplasmosis/diagnóstico , Humanos , Huésped Inmunocomprometido , Itraconazol/uso terapéutico , Enfermedades Pulmonares Fúngicas/diagnóstico , Enfermedades Pulmonares Fúngicas/tratamiento farmacológico , Enfermedades Pulmonares Fúngicas/etiología , Enfermedades Maxilares/tratamiento farmacológico , Enfermedades Maxilares/etiología , Enfermedades Maxilares/microbiología , Persona de Mediana Edad , Osteólisis/microbiologíaRESUMEN
BACKGROUND: Langerhans cell histiocytosis is a sporadic disease caused by an uncontrolled pathogenic clonal proliferation of dendritic cells that have Langerhans cell characteristics. New treatment protocols provided by the HISTSOC-LCH-III (NCT00276757) trial show an improvement in the survival of children with langerhans cell histiocytosis. CASE PRESENTATION: We report a case of Langerhans cell histiocytosis, which presented as an osteolytic lesion of the left pre-maxillae enclosing the deciduous incisor and canine in a 7-month-old white Italian boy. He was treated with chemotherapy. He achieved complete remission after 7 months and after 24 months no signs of recurrence were observed. CONCLUSIONS: As a result of this treatment, anesthetic sequelae and loss of teeth were avoided; in addition, we prevented a loss of the vertical dimension of occlusion.
Asunto(s)
Antineoplásicos/uso terapéutico , Glucocorticoides/uso terapéutico , Histiocitosis de Células de Langerhans/terapia , Enfermedades Maxilares/tratamiento farmacológico , Prednisona/uso terapéutico , Vinblastina/uso terapéutico , Esquema de Medicación , Histiocitosis de Células de Langerhans/diagnóstico por imagen , Histiocitosis de Células de Langerhans/patología , Humanos , Lactante , Imagen por Resonancia Magnética , Masculino , Enfermedades Maxilares/diagnóstico por imagen , Enfermedades Maxilares/patología , Tomografía Computarizada por Rayos X , Extracción DentalRESUMEN
Hemophagocytic lymphohistiocytosis (HLH) is a rare and severe syndrome usually associated with a cytotoxicity deficiency, which leads to an excess of immune response driven by activated macrophages and cytotoxic T cells. In children, HLH can be genetic, as part of a familial lymphohistiocytosis, or secondary: the most frequent causes are systemic-onset juvenile idiopathic arthritis, hematological malignancies, and severe infections, especially with Ebstein-Barr virus or leishmaniosis. We report on the case of a 3-year-old girl with no past medical history, who presented inaugural Pseudomonas aeruginosa maxillary osteitis, with secondary HLH. The rarity of this osteitis, the characteristics of the pathogen, and the onset of HLH oriented the diagnosis toward primary immunodeficiencies, malignancies, or systemic diseases. Steroids were initiated at 2mg/kg/day and were very effective in improving the systemic symptoms. Antibiotic therapy was continued unchanged. A few days after discontinuation of steroids, while the patient was still under antibiotics, she presented with erythroderma. Skin biopsy revealed eosinophil infiltrate in line with the diagnosis of a drug reaction with eosinophilia and systemic symptoms (DRESS), even though we only observed very transient eosinophilia, up to 0.98G/L, during HLH. Stopping antibiotics normalized the symptoms without using systemic corticosteroids. Patch tests confirmed an allergy to piperacillin. These atypical manifestations of DRESS underline that causative diagnosis of HLH is challenging, and DRESS syndrome should be considered.
Asunto(s)
Síndrome de Hipersensibilidad a Medicamentos/diagnóstico , Linfohistiocitosis Hemofagocítica/diagnóstico , Enfermedades Maxilares/diagnóstico , Osteítis/diagnóstico , Piperacilina/efectos adversos , Piperacilina/uso terapéutico , Infecciones por Pseudomonas/diagnóstico , Pseudomonas aeruginosa , Preescolar , Diagnóstico Diferencial , Femenino , Humanos , Linfohistiocitosis Hemofagocítica/tratamiento farmacológico , Enfermedades Maxilares/tratamiento farmacológico , Osteítis/tratamiento farmacológico , Pruebas del Parche , Infecciones por Pseudomonas/tratamiento farmacológicoRESUMEN
Sinus floor elevation with simultaneous implant placement in severely atrophic maxilla is challenging. The aim of this retrospective study was to evaluate the short-term performance of modified osteotome sinus floor elevation (OSFE) with concentrated growth factor (CGF) application and concurrent placement of a short implant in cases with residual bone height (RBH) of 2-4 mm. Twenty-five short implants were installed in 16 patients with mean RBH of 3.23 mm using modified OSFE with CGFs from January 2012 to April 2014. Postoperatively, the implants were clinically evaluated, and vertical bone gain (VBG) was measured using cone beam computed tomography. The mean duration of follow-up was 19.88 months (12-32 months). All the implants were stable with an overall survival rate of 100%. The mean VBG immediately after surgery was 9.21 mm. Six months later, significant reduction of alveolar bone height (2.90 ± 0.22 mm) was found (P < 0.05). During the second 6-month period, further alveolar bone resorption (0.14 ± 0.11 mm) was noted but without significance (P > 0.05). Within the limits of this study, modified OSFE with CGF application and simultaneous short implant placement could yield predictable clinical results for severely atrophic maxilla with RBH of 2-4 mm.
Asunto(s)
Atrofia/tratamiento farmacológico , Atrofia/cirugía , Péptidos y Proteínas de Señalización Intercelular/administración & dosificación , Enfermedades Maxilares/tratamiento farmacológico , Enfermedades Maxilares/cirugía , Reemplazo Osicular/métodos , Adulto , Anciano , Femenino , Estudios de Seguimiento , Humanos , Incrustaciones , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Resultado del Tratamiento , Adulto JovenRESUMEN
The deleterious effects of radiotherapy, including hypovascularity and hypocellularity, have made distraction of irradiated bones challenging. Animal studies, however, have demonstrated adjunctive measures such as the administration of deferoxamine to significantly improve bone regeneration across irradiated distraction gaps. In this report, the authors demonstrate, for the first time, enhanced bone formation following deferoxamine application in a patient following distraction of a previously irradiated maxilla. Computed tomography imaging of the pterygomaxillary buttress on the side of administration revealed significantly increased bone area and density relative to the contralateral buttress. This is the first presentation of clinical deferoxamine use to promote bone formation following irradiated bone distraction and highlights the promise for this adjunctive measure to make outcomes after distraction of irradiated bone more reliable.
Asunto(s)
Deferoxamina/uso terapéutico , Enfermedades Maxilares/tratamiento farmacológico , Osteogénesis por Distracción/métodos , Traumatismos por Radiación/tratamiento farmacológico , Animales , Regeneración Ósea/efectos de los fármacos , Humanos , Masculino , Maxilar/efectos de la radiación , Maxilar/cirugía , Enfermedades Maxilares/etiología , Enfermedades Maxilares/cirugía , Traumatismos por Radiación/complicaciones , Traumatismos por Radiación/cirugía , Neoplasias de la Retina/tratamiento farmacológico , Neoplasias de la Retina/radioterapia , Neoplasias de la Retina/cirugía , Retinoblastoma/tratamiento farmacológico , Retinoblastoma/radioterapia , Retinoblastoma/cirugía , Sideróforos/uso terapéutico , Adulto JovenRESUMEN
Periodontitis is a common chronic inflammatory disease, which leads to alveolar bone resorption. Healthy and functional alveolar bone, which can support the teeth and enable their movement, is very important for orthodontic treatment. Myricetin inhibited osteoclastogenesis by suppressing the expression of some genes, signaling pathways, and cytokines. This study aimed to investigate the effects of myricetin on alveolar bone loss in an ovariectomized (OVX) mouse model of periodontitis as well as in vitro osteoclast formation and bone resorption. Twenty-four healthy eight-week-old C57BL/J6 female mice were assigned randomly to four groups: phosphate-buffered saline (PBS) control (sham) OVX + ligature + PBS (vehicle), and OVX + ligature + low or high (2 or 5 mgâkg(-1)âday(-1), respectively) doses of myricetin. Myricetin or PBS was injected intraperitoneally (i.p.) every other day for 30 days. The maxillae were collected and subjected to further examination, including micro-computed tomography (micro-CT), hematoxylin and eosin (H&E) staining, and tartrate-resistant acid phosphatase (TRAP) staining; a resorption pit assay was also performed in vitro to evaluate the effects of myricetin on receptor activator of nuclear factor κ-B ligand (RANKL)-induced osteoclastogenesis. Myricetin, at both high and low doses, prevented alveolar bone resorption and increased alveolar crest height in the mouse model and inhibited osteoclast formation and bone resorption in vitro. However, myricetin was more effective at high dose than at low dose. Our study demonstrated that myricetin had a positive effect on alveolar bone resorption in an OVX mouse model of periodontitis and, therefore, may be a potential agent for the treatment of periodontitis and osteoporosis.
Asunto(s)
Pérdida de Hueso Alveolar/prevención & control , Flavonoides/uso terapéutico , Enfermedades Maxilares/prevención & control , Pérdida de Hueso Alveolar/tratamiento farmacológico , Pérdida de Hueso Alveolar/etiología , Animales , Línea Celular , Femenino , Flavonoides/administración & dosificación , Flavonoides/farmacología , Inyecciones Intraperitoneales , Maxilar/efectos de los fármacos , Maxilar/metabolismo , Maxilar/patología , Enfermedades Maxilares/tratamiento farmacológico , Enfermedades Maxilares/etiología , Ratones , Ratones Endogámicos C57BL , Osteogénesis , Ovariectomía/efectos adversos , Ligando RANK/metabolismoRESUMEN
PURPOSE: The treatment of patients with medication-related osteonecrosis of the jaw (MRONJ) is challenging. The purpose of the present study was to estimate the frequency and identify the factors associated with clinical improvement during treatment. PATIENTS AND METHODS: We designed and implemented a retrospective cohort study and enrolled a sample of subjects diagnosed with MRONJ between 2004 and 2015. The primary predictor variables were a set of heterogeneous variables grouped into the following categories: demographic (age and gender) and clinical (location of necrosis, therapy duration, medication type, disease stage, and treatment type). The primary outcome variable was the treatment outcome, defined as stable or worse and improved or healed. The descriptive, bivariate, and multiple logistic statistics were computed, and statistical significance was defined as P < .05. RESULTS: The sample included 337 subjects with a mean age of 68.9 years. Of the 337 subjects, 256 were women (76%). A total of 143 patients (42.2%) experienced spontaneous necrosis. Twenty-four (7.1%) had had exposure to targeted antiangiogenic agents. Those with stage 1 or 2 disease were more likely to have better outcomes than those with stage 3 disease (stage 1, adjusted odds ratio [OR] 3.4, P = .005; stage 2, adjusted OR 2.2, P = .03). Treatment type was a significant variable. Subjects undergoing surgery were 28 times more likely to have a positive outcome than those receiving nonoperative therapy (adjusted OR 28.7, P < .0001). CONCLUSIONS: Subjects with MRONJ who presented with less severe disease or who underwent operative treatment were most likely to have improvement or complete healing of their MRONJ-related lesions.
Asunto(s)
Osteonecrosis de los Maxilares Asociada a Difosfonatos/clasificación , Anciano , Alveolectomía/métodos , Inhibidores de la Angiogénesis/uso terapéutico , Antibacterianos/uso terapéutico , Antiinfecciosos/uso terapéutico , Osteonecrosis de los Maxilares Asociada a Difosfonatos/tratamiento farmacológico , Osteonecrosis de los Maxilares Asociada a Difosfonatos/cirugía , Conservadores de la Densidad Ósea/efectos adversos , Estudios de Cohortes , Femenino , Estudios de Seguimiento , Humanos , Masculino , Enfermedades Mandibulares/clasificación , Enfermedades Mandibulares/tratamiento farmacológico , Enfermedades Mandibulares/cirugía , Enfermedades Maxilares/clasificación , Enfermedades Maxilares/tratamiento farmacológico , Enfermedades Maxilares/cirugía , Persona de Mediana Edad , Antisépticos Bucales/uso terapéutico , Neoplasias/tratamiento farmacológico , Osteoporosis/tratamiento farmacológico , Osteotomía/métodos , Ligando RANK/antagonistas & inhibidores , Estudios Retrospectivos , Factores de Tiempo , Resultado del Tratamiento , Cicatrización de Heridas/fisiologíaRESUMEN
Osteoradionecrosis (ORN) of the jaw is a complication of radiation therapy for head and neck cancers. We report a case of ORN of the posterior maxilla treated with Er: YAG laser and a pedicled buccal fat pad (bichat bulla adipose) flap. A 69-year-old man presented complaining of pain on left maxilla. He had received high-dose radiotherapy (90 Gy) for squamous cell carcinoma of the left soft palate 2 years earlier. Clinical and radiographic examinations revealed ORN of the left maxillary molar region and maxillary sinusitis. Daily home care consisted of 0.9% saline irrigation and 0.8% H2O2 gel application. Sequestrectomy and tooth extraction were followed by debridement with Er: YAG laser and repair with a pedicled buccal fat pad flap. Complete resolution of ORN and maxillary sinusitis was established one year postsurgically. The excellent clinical outcome suggests that Er: YAG laser debridement and pedicled buccal fat pad flap are a viable option to treat ORN of the posterior maxilla.
Asunto(s)
Tejido Adiposo/trasplante , Láseres de Estado Sólido/uso terapéutico , Enfermedades Maxilares/cirugía , Osteorradionecrosis/cirugía , Colgajos Quirúrgicos/trasplante , Anciano , Autoinjertos/trasplante , Carcinoma de Células Escamosas/radioterapia , Desbridamiento/métodos , Estudios de Seguimiento , Humanos , Peróxido de Hidrógeno/uso terapéutico , Masculino , Enfermedades Maxilares/tratamiento farmacológico , Sinusitis Maxilar/tratamiento farmacológico , Sinusitis Maxilar/cirugía , Osteorradionecrosis/tratamiento farmacológico , Neoplasias Palatinas/radioterapia , Irrigación Terapéutica/métodos , Extracción Dental/métodos , Resultado del TratamientoRESUMEN
Disabled children with special health care needs are at high risk for oral disease. Myiasis is a rare condition that is associated with inadequate public and personal hygiene and is common in medically, mentally, and physically compromised individuals living in developing tropical countries. The purpose of this paper is to describe a case of oral myiasis in a 13-year-old Indian girl with spastic cerebral palsy.
Asunto(s)
Parálisis Cerebral/complicaciones , Enfermedades Maxilares/tratamiento farmacológico , Miasis/diagnóstico , Adolescente , Antibacterianos/uso terapéutico , Países en Desarrollo , Niños con Discapacidad , Femenino , Humanos , India , Insecticidas/uso terapéutico , Ivermectina/uso terapéutico , Miasis/tratamiento farmacológico , Factores de RiesgoRESUMEN
AIM: To evaluate the effects of fibroblast growth factor (FGF)-2 on the healing of surgical periodontal defects in rats with early, streptozotocin-induced diabetes. MATERIALS AND METHODS: Fifty Wistar rats were assigned to streptozotocin-induced diabetes or non-diabetes group. Periodontal defects were surgically created at maxillary first molars. Defects were treated with hydroxypropyl cellulose (HPC) or FGF-2 with HPC. Defect fill was evaluated by microcomputed tomography. Histological and immunohistochemical analyses were performed. RESULTS: Compared to vehicle alone, FGF-2 treatment yielded significantly greater bone volume and trabecular thickness in diabetes group. Diabetes group displayed reduced new bone formation and significantly longer epithelial down-growth compared to non-diabetes group. In diabetes group, FGF-2 treatment increased PCNA-positive cells and new bone formation after 2 weeks and suppressed epithelial down-growth, but new cementum formation was minimal even after 4 weeks. In diabetes group, overexpression of vascular endothelial growth factor was evident in cells within connective tissue, and no significant enhancement was observed by FGF-2 treatment. FGF-2 increased the expression of α-smooth muscle actin in diabetes group. CONCLUSIONS: Treatment of surgical periodontal defects in diabetic rats with the single application of FGF-2 provided beneficial effects primarily on new bone formation via increasing cell proliferation and regulating angiogenesis.
Asunto(s)
Pérdida de Hueso Alveolar/tratamiento farmacológico , Diabetes Mellitus Experimental/complicaciones , Factor 2 de Crecimiento de Fibroblastos/farmacología , Neovascularización Fisiológica/efectos de los fármacos , Actinas/análisis , Actinas/efectos de los fármacos , Animales , Proliferación Celular/efectos de los fármacos , Celulosa/análogos & derivados , Cementogénesis/efectos de los fármacos , Tejido Conectivo/efectos de los fármacos , Portadores de Fármacos , Inserción Epitelial/efectos de los fármacos , Masculino , Enfermedades Maxilares/tratamiento farmacológico , Diente Molar/patología , Osteogénesis/efectos de los fármacos , Antígeno Nuclear de Célula en Proliferación/análisis , Ratas , Ratas Wistar , Estreptozocina , Factores de Tiempo , Factor A de Crecimiento Endotelial Vascular/análisis , Factor A de Crecimiento Endotelial Vascular/efectos de los fármacos , Cicatrización de Heridas/efectos de los fármacos , Microtomografía por Rayos X/métodosRESUMEN
AIM: Vitamin D deficiency is considered to diminish bone regeneration. Yet, raising the serum levels takes months. A topic application of the active vitamin D metabolite, calcitriol, may be an effective approach. Thus, it becomes important to know the effect of vitamin D deficiency and local application on alveolar bone regeneration. MATERIAL AND METHODS: Sixty rats were divided into three groups; two vitamin depletion groups and a control group. Identical single defects (2 mm diameter) were created in the maxilla and mandible treated with calcitriol soaked collagen in one deficiency group while in the other two groups not. Histomorphometric analysis and micro CTs were performed after 1 and 3 weeks. Serum levels of 25(OH)D3 and PTH were determined. RESULTS: Bone formation rate significantly increased within the observation period in all groups. Bone regeneration was higher in the maxilla than in the mandible. However, bone regeneration was lower in the control group compared to vitamin depletion groups, with no significant effects by local administration of calcitriol (micro CT mandible p = 0.003, maxilla p < 0.001; histomorphometry maxilla p = 0.035, mandible p = 0.18). CONCLUSION: Vitamin D deficiency not necessarily impairs bone regeneration in the rat jaw and a single local calcitriol application does not enhance healing.
Asunto(s)
Pérdida de Hueso Alveolar/tratamiento farmacológico , Conservadores de la Densidad Ósea/administración & dosificación , Regeneración Ósea/efectos de los fármacos , Calcitriol/administración & dosificación , Deficiencia de Vitamina D/complicaciones , Administración Tópica , Pérdida de Hueso Alveolar/patología , Proceso Alveolar/efectos de los fármacos , Proceso Alveolar/patología , Animales , Matriz Ósea/efectos de los fármacos , Matriz Ósea/patología , Calcifediol/sangre , Calcificación Fisiológica/efectos de los fármacos , Masculino , Enfermedades Mandibulares/tratamiento farmacológico , Enfermedades Mandibulares/patología , Enfermedades Maxilares/tratamiento farmacológico , Enfermedades Maxilares/patología , Tamaño de los Órganos , Osteoblastos/efectos de los fármacos , Osteoblastos/patología , Osteogénesis/efectos de los fármacos , Hormona Paratiroidea/sangre , Ratas , Ratas Sprague-Dawley , Factores de Tiempo , Microtomografía por Rayos X/métodosRESUMEN
AIM: This study aimed to evaluate the adjunctive effect of LED light in platelet-derived growth factor (PDGF)-aided dentoalveolar osteogenesis. MATERIAL AND METHODS: Full-thickness osseous wounds were created on rat maxillae and were either unfilled or filled with poly-(D,L-lactide) and poly-(D,L-lactide-co-glycolide) microspheres encapsulating PDGF. Animals received daily 660 ± 25 nm LED light irradiation at 0, 10 (LD), or 20 (HD) J/cm(2) , were killed at days 4-28 (n = 6/group/time) and evaluated by microcomputed tomography (micro-CT), histology, and the expressions of osteopontin and tartrate-resistant acid phosphatase (TRAP). RESULTS: Greater osteogenesis was noted in the PDGF-treated defects at day 14. Under the LED light irradiation, osteogenesis was significantly greater in both LD and HD groups of the non-PDGF-treated defects, but only in the LD group of the PDGF-treated defects. No significant differences in osteogenesis among groups were noted at day 28. Greater bone marrow space was noted in the LED light-irradiated specimens, especially in the PDGF-treated defects at both time points. Osteopontin was significantly promoted in the LD group at both time points, and TRAP was significantly promoted in all LED light-irradiated groups at day 28. CONCLUSION: LED light could an adjunct to promote early PDGF-aided dentoalveolar osteogenesis by facilitating the osteoblast-osteoclast coupling.
Asunto(s)
Terapia por Luz de Baja Intensidad/métodos , Enfermedades Maxilares/terapia , Osteogénesis/fisiología , Proteínas Proto-Oncogénicas c-sis/uso terapéutico , Alveolo Dental/patología , Fosfatasa Ácida/análisis , Animales , Becaplermina , Materiales Biocompatibles/química , Densidad Ósea/efectos de los fármacos , Densidad Ósea/efectos de la radiación , Médula Ósea/patología , Terapia Combinada , Portadores de Fármacos , Isoenzimas/análisis , Ácido Láctico/química , Masculino , Enfermedades Maxilares/tratamiento farmacológico , Enfermedades Maxilares/radioterapia , Microesferas , Osteoblastos/patología , Osteoclastos/patología , Osteogénesis/efectos de los fármacos , Osteogénesis/efectos de la radiación , Osteopontina/análisis , Poliésteres/química , Ácido Poliglicólico/química , Copolímero de Ácido Poliláctico-Ácido Poliglicólico , Distribución Aleatoria , Ratas , Ratas Sprague-Dawley , Fosfatasa Ácida Tartratorresistente , Factores de Tiempo , Alveolo Dental/efectos de los fármacos , Alveolo Dental/efectos de la radiación , Microtomografía por Rayos X/métodosRESUMEN
Bisphosphonate induced necrosis of the jaws (BONJ) does not have a unique protocol of treatment and many therapeutic approaches have been arising in oral medicine with debatable results. A male and a female attended the University Oral Surgery Clinic presenting oral bone lesions induced by intravenous and oral bisphosphonates respectively as complications of dental extraction. Treatment included daily mouthwashes and weekly intra oral irrigations with 4 mg/L of aqueous-ozone, antibiotic therapy and sequential superficial debridment for sequestrectomies. Long-standing follow-ups showed complete mucosa covering of exposed bone area and resolution of purulent secretion. Antibacterial and antifungal properties of aqueous ozone may have played important roles in the treatment. The outcome measured intra oral examination and panoramic radiographs of the affected bone. The application of aqueous ozone daily mouthwashes and weekly professional irrigation were safe; free from adverse effects, easily of handling and worked as an important adjuvant therapeutic strategy for the treatment of BONJ.